TBPH vs AAPL: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Apple Inc in 2026
TBPH
Theravance Biopharma Inc
$17.23
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | TBPH | AAPL | Winner |
|---|---|---|---|
| Market Cap | $864.05M | N/A | TBPH |
| P/E Ratio | 8.15 | 33.32 | TBPH |
| EPS (TTM) | $2.06 | $8.11 | AAPL |
| Revenue Growth | 1.4% | 0.2% | TBPH |
| Gross Margin | 65.2% | 47.3% | TBPH |
Analyze TBPH
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or AAPL a better investment?
Comparing TBPH and AAPL: Theravance Biopharma Inc has a market cap of $864.05M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and AAPL?
TBPH (Theravance Biopharma Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or AAPL?
Based on P/E ratios, TBPH trades at a lower multiple (8.1x vs 33.3x).
Which is growing faster: TBPH or AAPL?
TBPH has higher revenue growth at 1.4% vs 0.2% for AAPL.
Which company is more profitable: TBPH or AAPL?
Theravance Biopharma Inc (TBPH) has higher gross margins at 65.2% compared to 47.3% for AAPL.
Which is the larger company: TBPH or AAPL?
Theravance Biopharma Inc (TBPH) is larger with a market cap of $864.05M compared to N/A for AAPL.
Should I buy TBPH or AAPL in 2026?
Both TBPH and AAPL have investment merit. TBPH trades at $17.23 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and AAPL stock?
Key differences: Market Cap ($864.05M vs N/A), P/E Ratio (8.1x vs 33.3x), Revenue Growth (1.4% vs 0.2%), Gross Margin (65.2% vs 47.3%).